Intravenous Procainamide for Predicting the Response of Sustained Ventricular Tachycardia to Type III Antiarrhythmic Drugs.
Cohen
TJ
Director of Pacemaker-Arrhythmia Center, Winthrop University Hospital, 259 First Street, Mineola, NY, 11501, USA.